Physician profile
Laura M Buehler
NPI 1346603701
$16,194.13
in general payments reported to CMS, 2019-2025
19 companies · $4,668 in 2025
The $4,668 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,082 · 2020: $156 · 2021: $289 · 2022: $517 · 2023: $3,337 · 2024: $5,145 · 2025: $4,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,799 · Food and Beverage: $5,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,799.29 |
| Food and Beverage | $5,350.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,964.63 | 2021-2025 | Prostep, Actishield, 1688 |
| Paragon 28, INC. | $2,594.94 | 2020-2025 | Portfolio, Bun-Yo-Matic, Precision Mis Bunion |
| Osteomed LLC | $1,189.11 | 2019 | |
| Organogenesis INC. | $862.38 | 2020-2025 | Affinity, Puraply, Puraply Wound Matrix |
| Gemini Medical LLC | $650.00 | 2019 | |
| Foundation Medical, LLC | $634.56 | 2024 | |
| Arthrex, INC. | $600.30 | 2024 | |
| Orthofix Medical, INC. | $193.06 | 2019-2025 | Physio-Stim |
| Medtronic, INC. | $138.76 | 2025 | Inceptiv |
| Osiris Therapeutics INC. | $106.51 | 2019 | |
| Wright Medical Technology, INC. | $99.86 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $30.56 | 2019 | |
| Kerecis Limited | $28.10 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Lifenet Health | $24.68 | 2024 | Theragenesis Wound Matrix |
| Bioventus LLC | $22.11 | 2025 | Exogen Ultrasound Bone Healing System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $15.58 | 2025 | V.A.C.Ulta, Activ.A.C. |
| In2bones USA, LLC | $15.14 | 2020 | |
| Smith+Nephew, INC. | $12.94 | 2019 | |
| Melinta Therapeutics, LLC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Buehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.